Bethlehem, PA USA — December 7, 2012 — Digestive Care, Inc. (DCI), announces the launch of the Pertzye® Co-Pay Assistance Program. This program is a cardless program that is offered through the Customer Support Department of the CF Services Pharmacy. The maximum out-of-pocket co-pay expense is only $10.00 (for each 30 day prescription fulfillment) for eligible patients whose insurance covers Pertzye®.
The enrollment process for the Pertzye® Co-Pay Assistance Program has three easy steps to follow. (1) Obtain prescription for PERTZYE® (pancrelipase) , the only bicarbonate-buffered enteric-coated pancrelipase drug product, from your physician. (2) Call 800-541-4959 to enroll over the phone. (3) Receive your Pertzye® order by mail. Note: This program is only offered for prescriptions filled through CF Services Pharmacy.
Patients receiving Medicare, Medicaid or any other State or Federal subsidized pharmacy benefit programs are not eligible for the Pertzye® Co-Pay Assistance Program. This program is valid until December 31, 2013.
About Digestive Care, Inc.
DCI is a fully integrated pharmaceutical company, founded in 1990, dedicated to developing unique pharmaceutical products to alleviate complications and symptoms of gastrointestinal disorders. For further information, please visit us at www.digestivecare.com.
Steve Berens, Vice President Sales and Marketing, Digestive Care, Inc., 1120 Win Drive, Bethlehem, PA 18017; Phone: 610-882-5950; e-mail: firstname.lastname@example.org